• Facebook
  • Twitter
Cancer World Archive
  • Magazine
HomeSenza categoriaEPO rules on contested gene patent

EPO rules on contested gene patent

Kathy Redmond

1 May 2005 Senza categoria 0

Number 6

Download pdf article

The European Patent Office (EPO) has decided that the European patent on mutations in breast and ovarian cancer susceptibility (EP 705903) is to be maintained in amended form.

Download full article

  • cancer drugs
  • European Patent Office
  • gene patents
Previous article
Next article

Related Articles

Spotlight on

How much is too much? Will someone please take charge of finding answers?

Spotlight on 27 October 2017 0
Drug Watch

Beyond the Herceptin hype…

Drug Watch 1 March 2006 0
News

Romanians protest against corruption that plagues hospitals

News 10 February 2017 0

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy